Replies to post #318317 on Amarin Corp Plc (AMRN)

[P-File]

You're missing the point. The average patient isn't going to pay $200+ for Vascepa. Most Vascepa scripts written after Reduce-It were off-label. Prior Auths are cutting off coverage for people who got scripts that way.

Not only does BCBS-TX have prior auth, but they've installed age limits on coverage as well.

[dmiller]

Did I say I wasn't going to continue buying it? The average person cannot and that was my point. Dolt!

[dmiller]

You just invited me back to this board. You can explain to the others why I'm now going to post again. They are not going to be happy with you.